Stage IIIa結腸・直腸S状部癌根治切除症例における再発危険因子の検討

Paul F. Engstrom, Juan Pablo Arnoletti, Al B. Benson, Yi-Jen Chen, Michael A. Choti, Harry S. Cooper, Anne Covey, Raza A. Dilawari, Dayna S. Early, Peter C. Enzinger, Marwan G. Fakih, James Fleshman, Charles Fuchs, Jean L. Grem, Krystyna Kiel, James A. Knol, Lucille A. Leong, Edward Lin, Mary F. Mulcahy, Sujata Rao, David P. Ryan, Leonard Saltz, David Shibata, John M. Skibber, Constantinos Sofocleous, James Thomas, Alan P. Venook, Christopher Willett, NCCN Clinical Practice Guidelines in Oncology: colon cancer. Journal of The National Comprehensive Cancer Network. ,vol. 7, pp. 778- 831 ,(2009) , 10.6004/JNCCN.2009.0056

D.J. Jonker, K. Spithoff, J. Maroun, Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer after Complete Resection: An Updated Practice Guideline Clinical Oncology. ,vol. 23, pp. 314- 322 ,(2011) , 10.1016/J.CLON.2011.02.010

Hans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, Marek P. Nowacki, Arie Figer, Jean Maroun, Timothy Price, Robert Lim, Eric Van Cutsem, Young-Suk Park, Joseph McKendrick, Claire Topham, Gemma Soler-Gonzalez, Filipo de Braud, Mark Hill, Florin Sirzén, Daniel G. Haller, Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients Journal of Clinical Oncology. ,vol. 26, pp. 102- 109 ,(2007) , 10.1200/JCO.2006.08.1075

E Van Cutsem, J Oliveira, None, Primary colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant treatment and follow-up Annals of Oncology. ,vol. 20, pp. 49- 50 ,(2009) , 10.1093/ANNONC/MDP126

Al B. Benson, Deborah Schrag, Mark R. Somerfield, Alfred M. Cohen, Alvaro T. Figueredo, Patrick J. Flynn, Monika K. Krzyzanowska, Jean Maroun, Pamela McAllister, Eric Van Cutsem, Melissa Brouwers, Manya Charette, Daniel G. Haller, American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer Journal of Clinical Oncology. ,vol. 22, pp. 3408- 3419 ,(2004) , 10.1200/JCO.2004.05.063

Thierry André, Corrado Boni, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Andrea Bonetti, Philip Clingan, John Bridgewater, Fernando Rivera, Aimery de Gramont, Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial Journal of Clinical Oncology. ,vol. 27, pp. 3109- 3116 ,(2009) , 10.1200/JCO.2008.20.6771

I. Chau, D. Cunningham, Adjuvant therapy in colon cancer—what, when and how? Annals of Oncology. ,vol. 17, pp. 1347- 1359 ,(2006) , 10.1093/ANNONC/MDL029

Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Marta Zaninelli, Philip Clingan, John Bridgewater, Isabelle Tabah-Fisch, Aimery de Gramont, None, Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer The New England Journal of Medicine. ,vol. 350, pp. 2343- 2351 ,(2004) , 10.1056/NEJMOA032709

Yasuhiro Shimada, Tetsuya Hamaguchi, Yoshihiro Moriya, Norio Saito, Yukihide Kanemitsu, Nobuhiro Takiguchi, Masayuki Ohue, Takeshi Kato, Yasumasa Takii, Toshihiko Sato, Naohiro Tomita, Shigeki Yamaguchi, Makoto Akaike, Hideyuki Mishima, Yoshiro Kubo, Junki Mizusawa, Kenichi Nakamura, Haruhiko Fukuda, Randomized phase III study of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients (pts) with stage III colon cancer (CC): Final results of Japan Clinical Oncology Group study (JCOG0205). Journal of Clinical Oncology. ,vol. 30, pp. 3524- 3524 ,(2012) , 10.1200/JCO.2012.30.15_SUPPL.3524